First topical treatment for premature ejaculation launched

Fortacin is the first topical treatment approved for...

GPs should no longer prescribe 18 'low value' treatments, NHS England rules

NHS England believes cutting access to the treatments,...

Sildenafil to be available over the counter

Men with erectile dysfunction (ED) will be able to...

Change of manufacturer for topical erectile dysfunction drug

HIV drug first to be approved in UK for pre-exposure prophylaxis

Truvada (emtricitabine/tenofovir) is indicated in combination...

Aviptadil/phentolamine launched as combination treatment for erectile dysfunction

Invicorp (aviptadil/phentolamine) is a new combination...

Women-only constipation treatment now licensed in men

Prescribers can now consider the 5HT4 agonist prucalopride...

Xiapex now indicated in Peyronie's disease

Xiapex (collagenase) is licensed to treat Peyronie's...

Prescribing restrictions for generic sildenafil removed

The Department of Health has removed restrictions requiring...

Prolia approved for male osteoporosis

Prolia (denosumab) can now be prescribed in men with...

Vitaros: a new topical treatment for erectile dysfunction

Vitaros, a topical cream formulation of alprostadil,...

Spedra launch provides new option for erectile dysfunction

Spedra (avanafil), a new PDE5 inhibitor, has been launched...

Vesomni: combination tablet for urinary storage symptoms associated with BPH

Vesomni is a fixed-dose, modified-release combination...

Priligy: first licensed treatment for premature ejaculation

Priligy (dapoxetine) is the first licensed treatment...

Xtandi: oral anti-androgen for metastatic prostate cancer

Xtandi (enzalutamide) is an anti-androgen licensed...

Nipatra: chewable sildenafil tablet for erectile dysfunction

Amdipharm Mercury has launched a chewable tablet formulation...

News in brief - August 2013

Other new launches, licence changes and updates relevant...

Zytiga approved for use before chemotherapy

The licence for Zytiga (abiraterone) has been extended...

Cialis: first PDE5 inhibitor licensed for benign prostatic hyperplasia

Tadalafil (Cialis) has been approved for the treatment...

NICE approval for denosumab in cancer

The osteoclast-targeting antibody denosumab has been...